Multicenter study of a novel topical interleukin-1 receptor inhibitor, isunakinra, in subjects with moderate to severe dry eye disease
Eye & Contact Lens: Science and Clinical Practice | Sep 01, 2017
Most read this week
Eye & Contact Lens: Science and Clinical Practice | Sep 01, 2017